Atlas Trials

DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Clinical trial NCT00005091 · COMPLETED

Trial details

NCT number
NCT00005091
Sponsor
Daiichi Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
1999-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.